Vijaypd Ceutical MD, chairman, board of directors and AGM
NSE: VIJAYPDRetailing
Share price at the NSE close on 23 Oct 2026. Previous close ₹80.35.
- Under NSE's short-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹162 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 May 2026
- 32.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 30 May 2026
- 9.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.64
- Volume, NSEVolume. Shares traded on the last trading day.
- 18,000
Vijaypd Ceutical board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/s. J D Shah AssociatesPeer-review certificate valid to Mar 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Vijaypd Ceutical AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Vijaypd Ceutical share news and announcements
Annual general meeting, 30 Sep 2026
596 shareholders on the register on 23 Sep 2026; present: 5 promoters and 0 others; votes counted by NIKUNJ KANABAR / NIKUNJ KANABAR & ASSOCIATES.The company's voting result (opens in a new tab)
- ADOPTION OF AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTSOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
- APPOINTMENT OF MR. NARENDRA NAGINDAS SHAH (DIN: 09634043) AS NON-EXECUTIVE DIRECTOR, LIABLE TO RETIRE BY ROTATIONOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
- REMUNERATION TO DIRECTORS EXCEEDING THE OVERALL MANAGERIAL REMUNERATION LIMIT AS PER THE PROVISIONS OF SECTION 197 OF THE COMPANIES ACT 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
- APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS WITH M/S. SIDDHARTH DRUGS PRIVATE LIMITEDOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 27.70% · promoters 0.00% · institutions 0.00% · other public 65.31%
- APPROVAL FOR MATERIAL RELATED PARTY TRANSACTIONS WITH M/S. ZEN PHARMACEUTICALSOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 27.70% · promoters 0.00% · institutions 0.00% · other public 65.31%
- TO APPROVE THE REMUNERATION PAYABLE TO MR. NARENDRA NAGINDAS SHAH (DIN: 09634043), NON-EXECUTIVE DIRECTOR OF THE COMPANYSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
- TO OBTAIN APPROVAL TO ADVANCE ANY LOAN/GIVE GUARANTEE/PROVIDE SECURITY UNDER SECTION 185 OF THE COMPANIES ACT, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
- INCREASING THE REMUNERATION OF MR. SAMIT MADHUKAR SHAH (DIN: 09634053), CHAIRMAN AND MANAGING DIRECTOR OF THE COMPANYSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
- INCREASING THE REMUNERATION OF MR. BHAVIN DHIRENDRA SHAH (DIN: 09839989), WHOLE TIME DIRECTOR OF THE COMPANYSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
- INCREASING THE REMUNERATION OF MR. RAHUL JITENDRA SHAH (DIN: 09837954), WHOLE TIME DIRECTOR OF THE COMPANYSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 18.39% · promoters 27.67% · institutions 0.00% · other public 6.53%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesSep 2025 | 19.25 | Funding of capital expenditure requirements of our company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of new machineries in MIDC - Shrirampur, Ahmednagar, Maharashtra | 10.83 | 2.27 | No |
| Public IssuesSep 2025 | 19.25 | Repayment/prepayment of all or certain of our borrowings availed of by our Company | 5.10 | 5.10 | No |
| Public IssuesSep 2025 | 19.25 | General corporate purposes | 0.74 | 0.74 | No |
| Public IssuesSep 2025 | 19.25 | Issue related Expenses | 2.58 | 2.58 | No |